Role of biometric characteristics of the uterine junctional zone in fertility outcomes in patients with adenomyosis

Ekaterina K. Orekhova , Olga A. Zhandarova , Igor Yu. Kogan

Journal of obstetrics and women's diseases ›› 2021, Vol. 70 ›› Issue (3) : 41 -50.

PDF (288KB)
Journal of obstetrics and women's diseases ›› 2021, Vol. 70 ›› Issue (3) : 41 -50. DOI: 10.17816/JOWD65046
Original study articles
research-article

Role of biometric characteristics of the uterine junctional zone in fertility outcomes in patients with adenomyosis

Author information +
History +
PDF (288KB)

Abstract

BACKGROUND: The uterine junctional zone is the inner part of the myometrium. Dysfunction of the zone may underlie the pathogenesis of adenomyosis and its clinical manifestations, while biometric characteristics of the zone are currently considered as promising early diagnostic criteria for this disease. Adenomyosis has traditionally been associated with parity and intrauterine interventions, primarily in older patients. However, modern imaging tools often allow diagnosing the disease in young patients with infertility and an unburdened gynecological history. It is assumed that the detection of changes in the structure and function of the uterine junctional zone in adenomyosis can be the basis for predicting fertility outcomes and complications of pregnancy, as well as for the development of promising therapeutic strategies at the pregravid stage.

AIM: The aim of this study was to assess the influence of biometric characteristics of the uterine junctional zone on pregnancy outcomes, depending on the parity and intrauterine interventions in patients with adenomyosis.

MATERIALS AND METHODS: This prospective study included 102 patients aged 22–39 years old with ultrasound features of adenomyosis who were going to conceive. The patients were divided into two groups: Group 1 (n = 58) consisted of nulliparous patients with no history of previous intrauterine interventions, and Group 2 (n = 44) comprised multipara women with a history of labor and / or intrauterine interventions. Using magnetic resonance imaging, we evaluated minimal, average and maximal junctional zone thicknesses, junctional zone deferential and a ratio of junctional zone thickness to myometrium thickness. Thresholds of biometric characteristics of the uterine junctional zone for adverse pregnancy outcomes were estimated.

RESULTS: The frequencies of pregnancy and retrochorial hematoma in patients of Groups 1 and 2 in the first trimester of pregnancy did not differ significantly and amounted to 43.1% and 38.6%, 13.8% and 22.7%, respectively, p > 0.05. Adverse pregnancy outcomes were diagnosed in 63.8% of patients in Group 1 and in 68.2% of patients in Group 2, p > 0.05. In Group 1, the frequency of retrochorial hematoma depended on the initial junctional zone deferential, as well as on the initial average and maximal junctional zone thicknesses, junctional zone deferentials and ratios of junctional zone thickness to myometrium thickness, which, with an adverse pregnancy outcome, were 1.7–2.5 times higher than those in patients with a favorable outcome, p > 0.05. In Group 2, adverse pregnancy outcomes were recorded with significantly higher values of average and maximal junctional zone thicknesses and junctional zone deferential. ROC curves were constructed using data of logistic regression analysis based on biometric characteristics of the uterine junctional zone to predict spontaneous abortion and infertility in patients with adenomyosis.

CONCLUSIONS: Fertility outcomes in patients with adenomyosis depend on a complex of biometric characteristics of the uterine junctional zone as determined by magnetic resonance imaging.

Keywords

uterine junctional zone / adenomyosis / infertility / miscarriage / pregnancy / magnetic resonance imaging

Cite this article

Download citation ▾
Ekaterina K. Orekhova, Olga A. Zhandarova, Igor Yu. Kogan. Role of biometric characteristics of the uterine junctional zone in fertility outcomes in patients with adenomyosis. Journal of obstetrics and women's diseases, 2021, 70(3): 41-50 DOI:10.17816/JOWD65046

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Pechenikova VA, Akopyan RA, Kvetnoy IM. Pathogenetic mechanisms of internal genital endometriosis – adenomyosis development and progression. Journal of obstetrics and women’s diseases. 2015;64(6):51–57. (In Russ.). DOI: 10.17816/JOWD64651-57

[2]

Печеникова В.А., Акопян Р.А., Кветной И.М. К вопросу о патогенетических механизмах развития и прогрессии внутреннего генитального эндометриоза – аденомиоза // Журнал акушерства и женских болезней. 2015. Т. 64. № 6. C. 51–57. DOI: 10.17816/JOWD64651-57

[3]

Vercellini P, Consonni D, Dridi D, et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29(5):964–977. DOI: 10.1093/humrep/deu041

[4]

Vercellini P., Consonni D., Dridi D. et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis // Hum. Reprod. 2014. Vol. 29. No. 5. P. 964–977. DOI: 10.1093/humrep/deu041

[5]

Parazzini F, Vercellini P, Panazza S, et al. Risk factors for adenomyosis. Hum Reprod. 1997;12(6):1275–1279. DOI: 10.1093/humrep/12.6.1275

[6]

Parazzini F., Vercellini P., Panazza S. et al. Risk factors for adenomyosis // Hum. Reprod. 1997. Vol. 12. No. 6. P. 1275–1279. DOI: 10.1093/humrep/12.6.1275

[7]

Kishi Y, Yabuta M, Taniguchi F. Who will benefit from uterus-sparing surgery in adenomyosis-associated subfertility? Fertil Steril. 2014;102(3):802–807.e1. DOI: 10.1016/j.fertnstert.2014.05.028

[8]

Kishi Y., Yabuta M., Taniguchi F. Who will benefit from uterus-sparing surgery in adenomyosis-associated subfertility? // Fertil. Steril. 2014. Vol. 102. No. 3. P. 802–807.e1. DOI: 10.1016/j.fertnstert.2014.05.028

[9]

Chapron C, Tosti C, Marcellin L, et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum Reprod. 2017;32(7):1393–1401. DOI: 10.1093/humrep/dex088

[10]

Chapron C., Tosti C., Marcellin L. et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes // Hum. Reprod. 2017. Vol. 32. No. 7. P. 1393–1401. DOI: 10.1093/humrep/dex088

[11]

Leyendecker G, Bilgicyildirim A, Inacker M, et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015;291(4):917–932. DOI: 10.1007/s00404-014-3437-8

[12]

Leyendecker G., Bilgicyildirim A., Inacker M. et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study // Arch. Gynecol. Obstet. 2015. Vol. 291. No. 4. P. 917–932. DOI: 10.1007/s00404-014-3437-8

[13]

Kunz G, Beil D, Deininger H, et al. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod. 1996;11(3):627–632. DOI: 10.1093/humrep/11.3.627

[14]

Kunz G., Beil D., Deininger H. et al. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy // Hum. Reprod. 1996. Vol. 11. No. 3. P. 627–632. DOI: 10.1093/humrep/11.3.627

[15]

Brosens I, Derwig I, Brosens J, et al. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod. 2010;25(3):569–574. DOI: 10.1093/humrep/dep474

[16]

Brosens I., Derwig I., Brosens J. et al. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? // Hum. Reprod. 2010. Vol. 25. No. 3. P. 569–574. DOI: 10.1093/humrep/dep474

[17]

Hricak H, Alpers C, Crooks LE, Sheldon PE. Magnetic resonance imaging of the female pelvis: initial experience. Am J Roentgenol. 1983;141(6):1119–1128. DOI: 10.2214/ajr.141.6.1119

[18]

Hricak H., Alpers C., Crooks L.E., Sheldon P.E. Magnetic resonance imaging of the female pelvis: initial experience // Am. J. Roentgenol. 1983. Vol. 141. No. 6. P. 1119–1128. DOI: 10.2214/ajr.141.6.1119

[19]

Bazot M, Cortez A, Darai E, et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod. 2001;16(11):2427–2433. DOI: 10.1093/humrep/16.11.2427

[20]

Bazot M., Cortez A., Darai E. et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology // Hum. Reprod. 2001. Vol. 16. No. 11. P. 2427–2433. DOI: 10.1093/humrep/16.11.2427

[21]

Reinhold C, McCarthy S, Bret PM, et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology. 1996;199(1):151–158. DOI: 10.1148/radiology.199.1.8633139

[22]

Reinhold C., McCarthy S., Bret P.M. et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation // Radiology. 1996. Vol. 199. No. 1. P. 151–158. DOI: 10.1148/radiology.199.1.8633139

[23]

Tosti C, Zupi E, Exacoustos C. Could the uterine junctional zone be used to identify early-stage endometriosis in women? Womens Health (Lond). 2014;10(3):225–227. DOI: 10.2217/whe.14.20

[24]

Tosti C., Zupi E., Exacoustos C. Could the uterine junctional zone be used to identify early-stage endometriosis in women? // Womens Health (Lond). 2014. Vol. 10. No. 3. P. 225–227. DOI: 10.2217/whe.14.20

[25]

Piver P. Facteurs utérins limitant la prise en charge en AMP [Uterine factors limiting ART coverage]. J Gynecol Obstet Biol Reprod (Paris). 2005;34(7 Pt 2):5S30–5S33. DOI: 10.1016/S0368-2315(05)82919-9

[26]

Piver P. Facteurs utérins limitant la prise en charge en AMP [Uterine factors limiting ART coverage] // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2005. Vol. 34. No. 7. Pt. 2. P. 5S30-5S33. DOI: 10.1016/S0368-2315(05)82919-9

[27]

Maubon A, Faury A, Kapella M, et al. Uterine junctional zone at magnetic resonance imaging: a predictor of in vitro fertilization implantation failure. J Obstet Gynaecol Res. 2010;36(3):611–618. DOI: 10.1111/j.1447-0756.2010.01189.x

[28]

Maubon A., Faury A., Kapella M. et al. Uterine junctional zone at magnetic resonance imaging: a predictor of in vitro fertilization implantation failure // J. Obstet. Gynaecol. Res. 2010. Vol. 36. No. 3. P. 611–618. DOI: 10.1111/j.1447-0756.2010.01189.x

[29]

Lazzarin N, Exacoustos C, Vaquero E, et al. Uterine junctional zone at three-dimensional transvaginal ultrasonography in patients with recurrent miscarriage: a new diagnostic tool? Eur J Obstet Gynecol Reprod Biol. 2014;174:128–132. DOI: 10.1016/j.ejogrb.2013.12.014

[30]

Lazzarin N., Exacoustos C., Vaquero E. et al. Uterine junctional zone at three-dimensional transvaginal ultrasonography in patients with recurrent miscarriage: a new diagnostic tool? // Eur. J. Obstet. Gynecol. Reprod. Biol. 2014. Vol. 174. P. 128–132. DOI: 10.1016/j.ejogrb.2013.12.014

[31]

Dueholm M, Lundorf E, Hansen ES, et al. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril. 2001;76(3):588–594. DOI: 10.1016/s0015-0282(01)01962-8

[32]

Dueholm M., Lundorf E., Hansen E.S. et al. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis // Fertil. Steril. 2001. Vol. 76. No. 3. P. 588–594. DOI: 10.1016/s0015-0282(01)01962-8

[33]

Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408. DOI: 10.1002/ijgo.12666

[34]

Munro M.G., Critchley H.O.D., Fraser I.S.; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions // Int. J. Gynaecol. Obstet. 2018. Vol. 143. No. 3. P. 393–408. DOI: 10.1002/ijgo.12666

[35]

Adamjan LV, Kulakov VI, Andreeva EN. Jendometriozy: rukovodstvo dlja vrachej. 2nd ed. Moscow: Medicina; 2006. (In Russ.)

[36]

Адамян Л.В., Кулаков В.И., Андреева Е.Н. Эндометриозы: руководство для врачей. 2-е изд. Москва: Медицина, 2006.

[37]

Harada T, Taniguchi F, Amano H, et al. Adverse obstetrical outcomes for women with endometriosis and adenomyosis: A large cohort of the Japan Environment and Children’s Study. PLoS One. 2019;14(8):e0220256. DOI: 10.1371/journal.pone.0220256

[38]

Harada T., Taniguchi F., Amano H. et al. Adverse obstetrical outcomes for women with endometriosis and adenomyosis: A large cohort of the Japan Environment and Children’s Study // PLoS One. 2019. Vol. 14. No. 8. P. e0220256. DOI: 10.1371/journal.pone.0220256

[39]

Smol’nikova VJu. Jekstrakorporal’noe oplodotvorenie i perenos jembrionov v polost’ matki v lechenie besplodija, obuslovlennogo genital’nym jendometriozom (klinicheskie i jembriologicheskie aspekty). [dissertation abstract]. Moscow; 2020. (In Russ.). [cited May 23 2021]. Available from: http://medical-diss.com/medicina/ekstrakorporalnoe-oplodotvorenie-i-perenos-embrionov-v-polost-matki-v-lechenii-besplodiya-obuslovlennogo-genitalnym-endom

[40]

Смольникова В.Ю. Экстракорпоральное оплодотворение и перенос эмбрионов в полость матки в лечении бесплодия, обусловленного генитальным эндометриозом (клинические и эмбриологические аспекты): автореф. дис. … д-ра мед. наук. Москва, 2002. [дата обращения 23.05.2021]. Доступ по ссылке: http://medical-diss.com/medicina/ekstrakorporalnoe-oplodotvorenie-i-perenos-embrionov-v-polost-matki-v-lechenii-besplodiya-obuslovlennogo-genitalnym-endom

[41]

Asif S, Henderson I, Fenning NR. Adenomyosis and its effect on reproductive outcomes. J Women’s Health. 2014;3(6):207. DOI: 10.4172/2167-0420.1000207

[42]

Asif S., Henderson I., Fenning N.R. Adenomyosis and its effect on reproductive outcomes // J. Women’s Health. 2014. Vol. 3. No. 6. P. 207. DOI: 10.4172/2167-0420.1000207

[43]

Puente JM, Fabris A, Patel J, et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol. 2016;14(1):60. DOI: 10.1186/s12958-016-0185-6

[44]

Puente J.M., Fabris A., Patel J. et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease // Reprod. Biol. Endocrinol. 2016. Vol. 14. No. 1. P. 60. DOI: 10.1186/s12958-016-0185-6

[45]

Tocci A, Greco E, Ubaldi FM. Adenomyosis and ‘endometrial-subendometrial myometrium unit disruption disease’ are two different entities. Reprod Biomed Online. 2008;17(2):281–291. DOI: 10.1016/s1472-6483(10)60207-6

[46]

Tocci A., Greco E., Ubaldi F.M. Adenomyosis and ‘endometrial-subendometrial myometrium unit disruption disease’ are two different entities // Reprod. Biomed. Online. 2008. Vol. 17. No. 2. P. 281–291. DOI: 10.1016/s1472-6483(10)60207-6

[47]

Werth R, Grusdew W. Untersuchungen über die Entwicklung und Morphologie der menschlichen Uterusmuskulatur. Arch Gynak. 1898;55:325–413. DOI: 10.1007/BF01981003. [cited May 23 2021]. Available from: https://link.springer.com/article/10.1007/BF01981003

[48]

Werth R., Grusdew W. Untersuchungen über die Entwicklung und Morphologie der menschlichen Uterusmuskulatur // Arch. Gynak. 1898. Vol. 55. P. 325–413. [cited May 23 2021]. Available from: https://link.springer.com/article/10.1007/BF01981003. DOI: 10.1007/BF01981003

[49]

Mehasseb MK, Bell SC, Brown L, et al. Phenotypic characterisation of the inner and outer myometrium in normal and adenomyotic uteri. Gynecol Obstet Invest. 2011;71(4):217–224. DOI: 10.1159/000318205

[50]

Mehasseb M.K., Bell S.C., Brown L. et al. Phenotypic characterisation of the inner and outer myometrium in normal and adenomyotic uteri // Gynecol. Obstet. Invest. 2011. Vol. 71. No. 4. P. 217–224. DOI: 10.1159/000318205

[51]

Fukui A, Funamizu A, Fukuhara R, Shibahara H. Expression of natural cytotoxicity receptors and cytokine production on endometrial natural killer cells in women with recurrent pregnancy loss or implantation failure, and the expression of natural cytotoxicity receptors on peripheral blood natural killer cells in pregnant women with a history of recurrent pregnancy loss. J Obstet Gynaecol Res. 2017;43(11):1678–1686. DOI: 10.1111/jog.13448

[52]

Fukui A., Funamizu A., Fukuhara R., Shibahara H. Expression of natural cytotoxicity receptors and cytokine production on endometrial natural killer cells in women with recurrent pregnancy loss or implantation failure, and the expression of natural cytotoxicity receptors on peripheral blood natural killer cells in pregnant women with a history of recurrent pregnancy loss // J. Obstet. Gynaecol. Res. 2017. Vol. 43. No. 11. P. 1678–1686. DOI: 10.1111/jog.13448

[53]

Yang JH, Chen MJ, Chen HF, et al. Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum Reprod. 2004;19(9):1974–1978. DOI: 10.1093/humrep/deh372

[54]

Yang J.H., Chen M.J., Chen H.F. et al. Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis // Hum. Reprod. 2004. Vol. 19. No. 9. P. 1974–1978. DOI: 10.1093/humrep/deh372

[55]

Harmsen MJ, Wong CFC, Mijatovic V, et al. Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review. Hum Reprod Update. 2019;25(5):647–671. DOI: 10.1093/humupd/dmz024

[56]

Harmsen M.J., Wong C.F.C., Mijatovic V. et al. Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review // Hum. Reprod. Update. 2019. Vol. 25. No. 5. P. 647–671. DOI: 10.1093/humupd/dmz024

[57]

Zhang Y, Yu P, Sun F, et al. Expression of oxytocin receptors in the uterine junctional zone in women with adenomyosis. Acta Obstet Gynecol Scand. 2015;94(4):412–418. DOI: 10.1111/aogs.12595

[58]

Zhang Y., Yu P., Sun F. et al. Expression of oxytocin receptors in the uterine junctional zone in women with adenomyosis // Acta Obstet. Gynecol. Scand. 2015. Vol. 94. No. 4. P. 412–418. DOI: 10.1111/aogs.12595

[59]

Huang M, Li X, Guo P, et al. The abnormal expression of oxytocin receptors in the uterine junctional zone in women with endometriosis. Reprod Biol Endocrinol. 2017;15(1):1. DOI: 10.1186/s12958-016-0220-7

[60]

Huang M., Li X., Guo P. et al. The abnormal expression of oxytocin receptors in the uterine junctional zone in women with endometriosis // Reprod. Biol. Endocrinol. 2017. Vol. 15. No. 1. P. 1. DOI: 10.1186/s12958-016-0220-7

RIGHTS & PERMISSIONS

Eсо-Vector

AI Summary AI Mindmap
PDF (288KB)

123

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/